Avenue Therapeutics, Inc. Made Big Gain

Thu, Jan 04, 2024 at 07:47 PM
Avenue Therapeutics, Inc. Made Big Gain

Avenue Therapeutics, Inc. (ATXI:NASDAQ) soared at $0.34, a gain of 94.5%. On Thu, Jan 04, 2024, ATXI:NASDAQ touched a New 2-Week High of $0.34. The stock appeared on our News Catalysts scanner on Thu, Jan 04, 2024 at 10:06 AM in the 'AGREEMENT' category. From Thu, Dec 21, 2023, the stock recorded 37.50% Up Days and 44.44% Green Days

About Avenue Therapeutics, Inc. (ATXI:NASDAQ)

Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of moderate to moderately severe postoperative pain.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.